The killing capacity of endogenous BCL-G was supported by subsequent studies in human osteosarcoma9, breast11 and prostate12 cancer cell lines, which showed a protective effect of BCL-G depletion during p53 activation or UV irradiation. This evidence concerns the gene TP53 and cancer.